Table III.

Univariate Analysis of Outcomes

Overall Survival
Variable	Reference Group	Total n=	Events	Censored	Hazard Ratio	Confidence Interval	p-Value
Age at HCT	Age < 40	37	17	20	0.96	0.37–2.48	0.93
PTCL versus CTCL	PTCL	37	17	20	2.00	0.77–5.20	0.16
Disease Status at HCT	1CR/2CR/PR	37	17	20	3.06	0.87–10.69	0.08*
PIT Group	1 / 2	21	7	14	1.06	0.21–5.50	0.94
Donor Type	Sibling	37	17	20	0.96	0.34–2.74	0.94
Conditioning Regimen	RIC	37	17	20	0.69	0.25–1.87	0.46
aGVHD Max Grade	None-II	37	17	20	2.17	0.49–9.62	0.31
cGVHD Max Grade	Limited	23	7	16	0.68	0.16–2.88	0.60
Progression-Free Survival
Variable	Reference Group	Total n=	Events	Censored	Hazard Ratio	Confidence Interval	p-Value
Age at HCT	Age < 40	37	19	18	0.94	0.38–2.32	0.90
PTCL versus CTCL	PTCL	37	19	18	1.56	0.62–3.89	0.34
Disease Status at HCT	1CR/2CR/PR	37	19	18	1..80	0.65–5.02	0.26
PIT Group	1 / 2	21	9	12	0.74	0.15–3.55	0.70
Donor Type	Sibling	37	19	18	0.76	0.27–2.10	0.59
Conditioning Regimen	RIC	37	19	18	0.58	0.22–1.54	0.27
aGVHD Max Grade	None-II	37	19	18	1.70	0.39–7.43	0.438
cGVHD Max Grade	Limited	23	9	14	1.46	0.37–5.79	0.59
Relapse/Progression
Variable	Reference Group	Total n=	Events	Censored	Hazard Ratio	Confidence Interval	p-Value
Age at HCT	Age < 40	37	9	18	0.67	0.18–2.49	0.55
PTCL versus CTCL	PTCL	37	9	18	1.10	0.27–4.42	0.89
Disease Status at HCT	1CR/2CR/PR	37	9	18	1.28	0.32–5.15	0.73
PIT Group	1 / 2	21	5	12	0.64	0.07–5.74	0.69
Donor Type	Sibling	37	9	18	0.27	0.03–2.16	0.22
Conditioning Regimen	RIC	37	9	18	0.69	0.17–2.75	0.59
aGVHD Max Grade	None-II	37	9	18	1.00	0.00-UND	0.99
cGVHD Max Grade	Limited	23	5	14	1.98	0.28–14.17	0.50

Univariate Cox proportional hazards analysis:

^**significance: p ≤0.05;

^*trend: p ≤ 0.1; Confidence intervals shows 95% confidence ranges. HCT–hematopoietic cell transplant, aGVHD–acute graft-versus-host disease, cGVHD–chronic graft-versus-host disease, PTCL–peripheral T-cell lymphoma, 1CR–first complete remission, 2CR–second complete remission, PR–partial remission, RIC-reduced-intensity conditioning, UND-undetermined.